122 related articles for article (PubMed ID: 35481416)
1. Patient perspectives and use of copayment assistance during the COVID-19 pandemic.
Wong WB; Jinnett K
J Manag Care Spec Pharm; 2023 Jan; 29(1):17-23. PubMed ID: 35481416
[No Abstract] [Full Text] [Related]
2. Copay assistance use and prescription abandonment across race, ethnicity, or household income levels for select rheumatoid arthritis and oral oncolytic medicines.
Wong WB; Donahue A; Thiesen J; Yeaw J
J Manag Care Spec Pharm; 2023 Mar; 29(3):324-334. PubMed ID: 36692908
[No Abstract] [Full Text] [Related]
3. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
[No Abstract] [Full Text] [Related]
4. Targeting Financial Toxicity in Oncology Specialty Pharmacy at a Large Tertiary Academic Medical Center.
Farano JL; Kandah HM
J Manag Care Spec Pharm; 2019 Jul; 25(7):765-769. PubMed ID: 31232209
[TBL] [Abstract][Full Text] [Related]
5. Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
Brouwer E; Yeung K; Barthold D; Hansen R
J Manag Care Spec Pharm; 2021 Jun; 27(6):732-742. PubMed ID: 34057391
[No Abstract] [Full Text] [Related]
6. The Financial Effect of Medicare Coverage Design and Safety Net Options for Cancer Care.
Bethay SS; Travis MJ; Batt SK; Bochenek SH; Schwieterman PA
J Manag Care Spec Pharm; 2020 Jan; 26(1):76-80. PubMed ID: 31880225
[TBL] [Abstract][Full Text] [Related]
7. Local specialty pharmacy and specialty clinic collaboration assists access to hepatitis C direct-acting antivirals.
Zhu J; Hazen RJ; Joyce C; Delpino A; Kirkham HS; Strickland CD; Markes-Wilson S; Kim T; Kang M; Rubin RA; Stein LL
J Am Pharm Assoc (2003); 2018; 58(1):89-93.e2. PubMed ID: 29154019
[TBL] [Abstract][Full Text] [Related]
8. Effect on medication adherence of applying a specialty pharmacy care model to nonspecialty medications: A quasi-experimental cohort study.
St James GJ; Duckworth DL; Bochenek SH; Rhudy C; Zeltner M; Tagavi AB; Platt TL
Am J Health Syst Pharm; 2023 Nov; 80(Suppl 4):S135-S142. PubMed ID: 36745621
[TBL] [Abstract][Full Text] [Related]
9. Health-system specialty pharmacy role and outcomes: A review of current literature.
Zuckerman AD; Whelchel K; Kozlicki M; Simonyan AR; Donovan JL; Gazda NP; Mourani J; Smith AM; Young L; Ortega M; Kelley TN
Am J Health Syst Pharm; 2022 Oct; 79(21):1906-1918. PubMed ID: 35916907
[TBL] [Abstract][Full Text] [Related]
10. The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors.
Seetasith A; Wong W; Tse J; Burudpakdee C
J Med Econ; 2019 May; 22(5):414-420. PubMed ID: 30729850
[TBL] [Abstract][Full Text] [Related]
11. ASHP National Survey of Health-System Specialty Pharmacy Practice-2020.
Stubbings J; Pedersen CA; Low K; Chen D
Am J Health Syst Pharm; 2021 Sep; 78(19):1765-1791. PubMed ID: 34345889
[TBL] [Abstract][Full Text] [Related]
12. Impact of financial medication assistance on medication adherence: a systematic review.
Hung A; Blalock DV; Miller J; McDermott J; Wessler H; Oakes MM; Reed SD; Bosworth HB; Zullig LL
J Manag Care Spec Pharm; 2021 Jul; 27(7):924-935. PubMed ID: 34185554
[No Abstract] [Full Text] [Related]
13. Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs.
Yeung K; Suh K; Basu A; Garrison LP; Bansal A; Carlson JJ
J Manag Care Spec Pharm; 2017 Oct; 23(10):1084-1090. PubMed ID: 28944726
[TBL] [Abstract][Full Text] [Related]
14. Characterizing Out-of-Pocket Payments and Financial Assistance for Patients Prescribed Abiraterone and Enzalutamide at an Academic Cancer Center Specialty Pharmacy.
Jeong AY; Schwartz EB; Roman AR; McDevitt RL; Oerline MK; Henry E; Veenstra CM; Caram MEV
JCO Oncol Pract; 2022 Feb; 18(2):e284-e292. PubMed ID: 34491783
[TBL] [Abstract][Full Text] [Related]
15. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
Peter ME; Markley B; DeClercq J; Choi L; Givens G; Zuckerman AD; Banks A
J Manag Care Spec Pharm; 2021 Feb; 27(2):256-262. PubMed ID: 33506731
[No Abstract] [Full Text] [Related]
16. Patient perceptions of copay card utilization and policies.
Cavalier D; Doherty B; Geonnotti G; Patel A; Peters W; Zona S; Shea L
J Mark Access Health Policy; 2023; 11(1):2254586. PubMed ID: 37692554
[TBL] [Abstract][Full Text] [Related]
17. Consumer perceptions about a community pharmacy-based medication take back program.
Thach AV; Brown CM; Pope N
J Environ Manage; 2013 Sep; 127():23-7. PubMed ID: 23669605
[TBL] [Abstract][Full Text] [Related]
18. Outpatient pharmaceutical care satisfaction survey through Telepharmacy during COVID-19 pandemic in Spain.
Mercadal-Orfila G; Lizeaga G; Fernández-Llamazares CM; Tortajada-Goitia B; García Cabrera E; Morillo-Verdugo R; Negro-Vega E
Farm Hosp; 2022 Oct; 46(7):69-85. PubMed ID: 36520562
[TBL] [Abstract][Full Text] [Related]
19. National survey of patient perspectives on cost discussions among recipients of copay assistance.
Lam AB; Nipp RD; Hasler JS; Hu BY; Zahner GJ; Robbins S; Wheeler SB; Tagai EK; Miller SM; Peppercorn JM
Oncologist; 2024 Jun; ():. PubMed ID: 38864681
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
